Real incidence and management of patients with suspected iodinated contrast media allergy in our area
Main Article Content
Keywords
contrast media, drug allergy, drug provocation test, hypersensitivity, skin tests
Abstract
Introduction: Adverse reactions to iodinated contrast media (ICM) are very common due to its widespread use. Despite the fact that overall incidence of hypersensitivity reactions (HSRs) to ICM is low, the risk of severe outcomes needs a careful patient evaluation and management.
Methods: We conducted a retrospective epidemiological study that included patients referred to our Allergy Unit for suspected allergy to ICM in whom we carried out a protocolized allergic study based on skin and drug provocation tests (DPT).
Results: A total of 108 patients were tested and allergy to ICM was confirmed in 29 (26.9%) and assumed in 9 (8.3%). All these patients tolerated DPT with alternative ICM. The most frequently involved contrasts in confirmed HSR were iodixanol and iohexol, and iopromida was the best tolerated. Out of a total of 125 DPT, we obtained 26 positive results with only two systemic reactions (mild).
Conclusion: In most of the patients in our sample, allergy to ICM was ruled out, and in allergic patients, tolerance to an alternative ICM was established. Our protocol is safe and allows patients to receive ICM in the future.
References
2 Vega, F., van de Ven, A.A.J.M., van der Molen, A.J. Cross-reactivity in hypersensitivity reactions to contrast agents: new classification and guide for clinical practice. Eur Radiol. 2024;34:7583–88. 10.1007/s00330-024-10872-8
3 Salas M, Gomez F, Fernandez TD, Dona I, Aranda A, Ariza A, et al. Diagnosis of immediate hypersensitivity reactions to radiocontrast media. Allergy. 2013;68(9):1203–6. 10.1111/all.12214
4 Torres MJ, Gomez F, Dona I, Rosado A, Mayorga C, Garcia I, et al. Diagnostic evaluation of patients with nonimmediate cutaneous hypersensitivity reactions to iodinated contrast media. Allergy. 2012;67(7):929–35. 10.1111/j.1398-9995.2012.02840.x
5 Schrijvers R, Breynaert C, Ahmedali Y, Bourrain JL, Demoly P, Chiriac AM. Skin testing for suspected iodinated contrast media hypersensitivity. J Allergy Clin Immunol,Pract. 2018;6(4):1246–54. 10.1016/j.jaip.2017.10.040
6 Sesé L, Gaouar H, Autegarden J-E, Alari A, Amsler E, A Vial-Dupuy, et al. Immediate hypersensitivity to iodinated contrast media: Diagnostic accuracy of skin tests and intravenous provocation test with low dose. Clin Exp Allergy. 2016;46(3):472–78. 10.1111/cea.12703
7 Brockow K, Romano A, Aberer W, Bircher AJ, Barbaud A, Bonadonna P, et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media–a European multicenter study. Allergy 2009;64(2):234-41. 10.1111/j.1398-9995.2008.01832.x
8 Meucci, E, Radice, A, Fassio, F, Sibilio, M, Iorno, M.L.C, Testi, S, et al. Diagnostic approach to hypersensitivity reactions to iodinated contrast media: A single-center experience on 98 patients. Eur Ann Allergy Clin Immunol. 2020;52(5):220–29. 10.23822/EurAnnACI.1764-1489.129
9 Kim S, Jeon KN, Jung JW, Park HK, Lee W, Lee J, et al. Substitution with low osmolar iodinated contrast agent to minimize recurrent immediate hypersensitivity reaction. Radiology. 2023;309(1). 10.1148/radiol.222467
10 Gracia-Bara MT, Moreno E, Laffond E, Muñoz-Bellido F, Lázaro M, Macías E, et al.Tolerability of iobitridol in patients with non-immediate hypersensitivity reactions to iodinated contrast media. Allergy. 2019;74(1):195–7. 10.1111/all.13603